Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Prognostic importance of obstructive sleep apnea and CPAP treatment for cardiovascular and mortality outcomes in patients with resistant hypertension: a prospective cohort study

Hypertension Research volume 46, pages 1020–1030 (2023)Cite this article

Abstract

The prognostic importance of obstructive sleep apnea (OSA) severity and other polysomnographic parameters in patients with resistant hypertension (RHT) has never been evaluated. We aimed to assess it in a prospective cohort of 422 individuals with RHT. OSA presence/severity was ascertained by complete polysomnography (PSG) at baseline. Multivariable Cox regressions assessed the risks associated with OSA severity and other PSG parameters (apnea-hypopnea index, sleep duration, nocturnal hypoxemia and periodic limb movements) for the primary (total cardiovascular events [CVEs] and all-cause mortality) and secondary outcomes (major CVEs). In the subgroup of patients with moderate/severe OSA, the risks associated with CPAP treatment were also estimated in relation to untreated individuals. One-hundred and eighty-six participants (44%) had no/mild OSA and 236 (56%) had moderate/severe OSA, and 67 of them were CPAP-treated. Over a mean follow-up of 5 years, there were 46 CVEs (37 major ones) and 44 all-cause deaths. Neither the presence of moderate/severe or severe OSA, nor being untreated during follow-up, was associated with significant excess risks for any outcome in relation to the subgroup with no/mild OSA. Similarly, no other PSG-derived parameter predicted any adverse outcome. Otherwise, CPAP treatment was associated with non-significant risk reductions of 37% for total CVEs, 49% for major CVEs and 63% for all-cause mortality in relation to those who remained untreated during follow-up. In conclusion, the presence/severity of OSA and its related PSG parameters were not associated with worse cardiovascular/mortality prognosis in patients with RHT. However, CPAP treatment might be protective in individuals with moderate/severe OSA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Epstein MD, Kristo D, Strollo PJ, Friedman N, Malhotra A, Patil SP, et al. Adult obstructive sleep apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5:263–76.

    Article  PubMed  Google Scholar 

  2. Loke YK, Brown JW, Kwok CS, Niruban A, Myint PK. Association of obstructive sleep apnea with risk of serious cardiovascular events: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2012;5:720–8.

    Article  PubMed  Google Scholar 

  3. Drager LF, McEvoy RD, Barbe F, Lorenzi-Filho G, Redline S. INCOSACT Initiative (International Collaboration of Sleep Apnea Cardiovascular Trialists). Sleep apnea and cardiovascular disease: lessons from recent trials and need for team science. Circulation 2017;136:1840–50.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Javaheri S, Barbe F, Campos-Rodriguez F, Dempsey JA, Khayat R, Javaheri S, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 2017;69:841–58.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Peker Y, Balcan B. Cardiovascular outcomes of continuous positive airway pressure therapy for obstructive sleep apnea. J Thorac Dis. 2018;10:S4262–79.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Qaseem A, Holty JE, Owens DK, Dallas P, Starkey M, Shekelle P. for the Clinical Guidelines Committee of the American College of Physicians. Management of obstructive sleep apnea in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013;159:471–83.

    PubMed  Google Scholar 

  7. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046–53.

    Article  PubMed  Google Scholar 

  8. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med. 2012;156:115–22.

    Article  PubMed  Google Scholar 

  9. Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunström E. Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with nonsleepy obstructive sleep apnea. The RICCADSA randomized controlled trial. Am J Respir Crit Care Med. 2016;194:613–20.

    Article  CAS  PubMed  Google Scholar 

  10. McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et al. SAVE Investigators and Coordinators. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N. Engl J Med. 2016;375:919–31.

    Article  PubMed  Google Scholar 

  11. Sánchez-de-la-Torre M, Sánchez-de-la-Torre A, Bertran S, Abad J, Duran-Cantolla J, Cabriada V, et al. Spanish Sleep Network. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial. Lancet. Respir Med. 2020;8:359–67.

    Google Scholar 

  12. Yu J, Zhou Z, McEvoy RD, Anderson CS, Rodgers A, Perkovic V, et al. Association of positive airway pressure with cardiovascular events and death in adults with sleep apnea: a systematic review and meta-analysis. JAMA. 2017;318:156–66.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Labarca G, Dreyse J, Drake L, Jorquera J, Barbe F. Efficacy of continuous positive airway pressure (CPAP) in the prevention of cardiovascular events in patients with obstructive sleep apnea: Systematic review and meta-analysis. Sleep Med Rev. 2020;52:101312.

    Article  PubMed  Google Scholar 

  14. Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58:811–7.

    Article  CAS  PubMed  Google Scholar 

  15. Muxfeldt ES, Margallo VS, Guimarães GM, Salles GF. Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension. Am J Hypertens. 2014;27:1069–78.

    Article  CAS  PubMed  Google Scholar 

  16. Sapiña-Beltrán E, Torres G, Benitez I, Fortuna-Gutiérrez AM, Márquez PP, Masa JF, et al. Prevalence, characteristics, and association of obstructive sleep apnea with blood pressure control in patients with resistant hypertension. Ann Am Thorac Soc. 2019;16:1414–21.

    Article  PubMed  Google Scholar 

  17. Martínez-García MA, Capote F, Campos-Rodríguez F, Lloberes P, Díaz de Atauri MJ, Somoza M, et al. Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA .2013;310:2407–15.

    Article  PubMed  Google Scholar 

  18. Muxfeldt ES, Margallo V, Costa LM, Guimarães G, Cavalcante AH, Azevedo JC, et al. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial. Hypertension. 2015;65:736–42.

    Article  CAS  PubMed  Google Scholar 

  19. Lei Q, Lv Y, Li K, Ma L, Du G, Xiang Y, et al. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a systematic review and meta-analysis of six randomized controlled trials. J Bras Pneumol. 2017;43:373–9.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Labarca G, Schmidt A, Dreyse J, Jorquera J, Enos D, Torres G, et al. Efficacy of continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA) and resistant hypertension (RH): Systematic review and meta-analysis. Sleep Med Rev. 2021;58:101446.

    Article  CAS  PubMed  Google Scholar 

  21. Navarro-Soriano C, Martínez-García MA, Torres G, Barbé F, Sánchez-de-la-Torre M, Caballero-Eraso C, et al. on behalf the Spanish Sleep Network. Long-term effect of CPAP treatment on cardiovascular events in patients with resistant hypertension and sleep apnea. Data from the HIPARCO-2 study. Arch Bronconeumol (Engl Ed). 2021;57:165–71.

    Article  PubMed  Google Scholar 

  22. Kim JW, Won TB, Rhee CS, Park YM, Yoon IY, Cho SW. Polysomnographic phenotyping of obstructive sleep apnea and its implications in mortality in Korea. Sci Rep. 2020;10:13207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Kendzerska T, Leung RS, Atzema CL, Chandy G, Meteb M, Malhotra A, et al. Cardiovascular consequences of obstructive sleep apnea in women: a historical cohort study. Sleep Med. 2020;68:71–9.

    Article  PubMed  Google Scholar 

  24. Trzepizur W, Blanchard M, Ganem T, Balusson F, Feuilloy M, Girault JM, et al. Sleep apnea-specific hypoxic burden, symptom subtypes, and risk of cardiovascular events and all-cause mortality. Am J Respir Crit Care Med. 2022;205:108–17.

    Article  PubMed  Google Scholar 

  25. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008;51:1403–19.

    Article  CAS  PubMed  Google Scholar 

  26. Bloch KV, de Melo AN, Nogueira AR. Prevalence of anti-hypertensive treatment adherence in patients with resistant hypertension and validation of three indirect methods for assessing treatment adherence. Cad Saúde Pública. 2008;24:2979–84.

    Article  PubMed  Google Scholar 

  27. Jones CR, Taylor K, Chowienczyk P, Poston L, Shennan AH. A validation of the Mobil O Graph (version 12) ambulatory blood pressure monitor. Blood Press Monit. 2000;5:233–8.

    Article  CAS  PubMed  Google Scholar 

  28. Cardoso CRL, Salles GF. Prognostic value of changes in aortic stiffness for cardiovascular outcomes and mortality in resistant hypertension: a cohort study. Hypertension. 2022;79:447–56.

    Article  CAS  PubMed  Google Scholar 

  29. Cardoso CRL, Salles GF. Prognostic impact of home blood pressures for adverse cardiovascular outcomes and mortality in patients with resistant hypertension: a prospective cohort study. Hypertension. 2021;78:1617–27.

    Article  CAS  PubMed  Google Scholar 

  30. Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. 2012;125:1635–42.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr, Crowley K, et al. REACH Registry Investigators. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur Heart J. 2013;34:1204–14.

    Article  CAS  PubMed  Google Scholar 

  32. Muntner P, Davis BR, Cushman WC, Bangalore S, Calhoun DA, Pressel SL, et al. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension. 2014;64:1012–21.

    Article  CAS  PubMed  Google Scholar 

  33. Dong JY, Zhang YH, Qin LQ. Obstructive sleep apnea and cardiovascular risk: meta-analysis of prospective cohort studies. Atherosclerosis. 2013;229:489–95.

    Article  CAS  PubMed  Google Scholar 

  34. Javaheri S, Martinez-Garcia MA, Campos-Rodriguez F. CPAP treatment and cardiovascular prevention: we need to change the design and implementation of our trials. Chest. 2019;156:431–7.

    Article  PubMed  Google Scholar 

  35. Drager LF, Lorenzi-Filho G. POINT: Should sleep studies be performed for all patients with poorly controlled hypertension? Yes. Chest. 2019;155:1095–7.

    Article  PubMed  Google Scholar 

  36. Cardoso CRL, Salles GF. COUNTERPOINT: Should sleep studies be performed for all patients with poorly controlled hypertension? No. Chest. 2019;155:1097–101.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This study was partially supported by grants from the Brazilian Ministry of Health (DECIT, Brazil) and Ministry of Science and Tecnology (FINEP, Brazil), and from the Conselho Brasileiro de Desenvolvimento Científico e Tecnológico (CNPq, Brazil) and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil). The sponsors have no role in study design, data collection and analysis, results interpretation or in preparation, review and approval of the manuscript.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University Hospital Clementino Fraga Filho, School of Medicine, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

    Claudia R. L. Cardoso & Gil F. Salles

Authors
  1. Claudia R. L. Cardoso
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gil F. Salles
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gil F. Salles.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cardoso, C.R.L., Salles, G.F. Prognostic importance of obstructive sleep apnea and CPAP treatment for cardiovascular and mortality outcomes in patients with resistant hypertension: a prospective cohort study. Hypertens Res 46, 1020–1030 (2023). https://doi.org/10.1038/s41440-023-01193-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-023-01193-2

Keywords

This article is cited by

Search

Advanced search

Quick links